References
- Consumer Healthcare Products Association. The value of OTC medicine to the United States [internet]. CHPA; January 2012. http://www.chpa.org/ValueofOTCMeds2012.aspx
- Willemsen KR, Harrington G. From patient to resource: the role of self-care in patient-centered care of minor ailments. SelfCare 2012;3:43-55
- Association of the European Self-Medication Industry. The economic and public health value of self medication [internet]. Association of the European Self-Medication Industry; June 2004. http://www.aesgp.eu/media/cms_page_media/68/2004study.pdf
- Hemminki E, Sihvo S. Finnish physicians’ opinions of vaginal estriol in self-care. Maturitas 1999;31:241-7
- World Health Organization (WHO). Guidelines for regulatory assessment of medicinal products for use in self-medication. Geneva: WHO; 2000. http://apps.who.int/medicinedocs/pdf/s2218e/s2218e.pdf
- Brass EP. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 2001;345:810-6
- Berkman ND, Sheridan SL, Donahue KE, et al. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med 2011;155:97-107
- Andrulis DP. Access to care is the centerpiece in the elimination of socioeconomic disparities in health. Ann Intern Med 1998;129:412-16
- Global health care outlook – battling costs while improving care [internet]. Deloitte; 2016. https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2016-health-care-outlook.pdf
- Polder JJ, Bonneux L, Meerding WJ, et al. Age-specific increases in health care costs. Eur J Public Health 2002;12:57-62
- Doyle Y, McKee M, Rechel B, et al. Meeting the challenge of population ageing. BMJ 2009;339:b3926
- Garza A. The aging population: the increasing effects on health care. Pharmacy Times 2016;82:1. http://www.pharmacytimes.com/publications/issue/2016/january2016/the-aging-population-the-increasing-effects-on-health-care
- Lopreite M, Mauro M. The effects of population ageing on health care expenditure: a Bayesian VAR analysis using data from Italy. Health Policy 2017;121:663-74
- Rees S, Williams A. Promoting and supporting self-management for adults living in the community with physical chronic illness: a systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter. JBI Libr Syst Rev 2009;7:492-582
- NHS England – Urgent and Emergency Care Review Team. High quality care for all, now and for future generations: transforming urgent and emergency care services in England. The evidence base from the urgent and emergency care review. NHS; 2013. https://www.england.nhs.uk/wp-content/uploads/2013/06/urg-emerg-care-ev-bse.pdf
- Self Care Forum. Self-care: The story so far…; 2013. http://www.selfcareforum.org/wp-content/uploads/2012/08/aboutselfcare.pdf
- London PA, Shostak D. Potential reduction in unnecessary visits to doctors from safe and appropriate use of OTC medicines could save consumers and taxpayers billions annually. 2011. http://www.yourhealthathand.org/images/uploads/London_Cost_Saving_Study_061711.pdf
- Consumerism, self-care trends and broader value of employee health. The Center for Workforce Health and Performance; 2016. http://www.tcwhp.org/sites/default/files/reports/CWHP%20Report%20August%202016_Consumerism_Self-Care%20Trends_Broader%20Value%20of%20Employee%20Health.pdf
- The value of OTC medicines in Australia 2014 [internet]. MacQuarie University Centre for the Health Economy (MUCHE); 2014. http://www.wsmi.org/wp-content/data/pdf/FINALWEBCOPYASMI_ValueStudy.pdf
- Shanahan C, de Lorimier R. Targeted use of complimentary medicines: potential health outcomes and cost savings in Australia. Frost & Sullivan; 2014. http://www.asmi.com.au/media/14046/final_frost_sullivan_report_photocopy_ready_8_oct_2014.pdf
- Anderson M, Bolton C, Morgan S, et al. The economics of self-medication. Kingston, Ontario: Queen’s Health Policy Research Unit; 1995
- Bureau of Labor Statistics. Medical care component of the Consumer Price Index [internet]. Bureau of Labor Statistics. https://www.bls.gov/cpi/
- Sullivan PW, Follin SL, Nichol MB. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis. Med Care 2003;41:1382-95
- Mansfield JE, Callahan D. Benefits of over-the-counter heartburn medication to consumers and the healthcare system [internet]. 2008. https://www.chpa.org/01_26_09_NielsenReportHeartburn.aspx
- Tasch RF, Goeree R, Henke CJ, et al. Switching the histamine h2 receptor antagonist famotidine to nonprescription status in Canada. Pharmacoeconomics 1996;9:61-75
- Rankin PJ, Tsvetkova IV, Estus E, et al. Managing access to dextromethorphan: cost implications of a potential over-the-counter to prescription-only conversion. Charles River Associates; 2016. http://www.crai.com/publication/managing-access-dextromethorphan-cost-implications-potential-over-counter-prescription
- Tfelt-Hansen P, Steiner TJ. Over-the-counter triptans for migraine: what are the implications? CNS Drugs 2007;21:877-83
- Millier A, Cohen J, Toumi M. Economic impact of a triptan Rx-to-OTC switch in six EU countries. PLoS One 2013;8:e84088
- Chen YH, Feng B, Chen ZW. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis. Exp Clin Endocrinol Diabetes 2012;120:116-20
- Pencina MJ, Navar-Boggan AM, D’Agostino RB Sr, et al. Application of new cholesterol guidelines to a population-based sample. N Engl J Med 2014;370:1422-31
- Stomberg C, Albaugh M, Shiffman S, et al. A cost-effectiveness analysis of over-the-counter statins. Am J Manag Care 2016;22:e294-e303
- Shanahan C. Healthcare cost savings of omega 3 food supplements in the European Union: economic implication of managing CVD through targeted enhanced nutrition. Frost and Sullivan; 2016. http://www.foodsupplementseurope.org/sites/0023/uploads/content/hccs-omega-3/hccs-omega-3-report.pdf
- Proprietary Association of Great Britain. Releasing capacity in general practice for 21st century healthcare. 2007 [Data on file]
- Collins JJ, Baase CM, Sharda CE, et al. The assessment of chronic health conditions on work performance, absence, and total economic impact for employers. J Occup Environ Med 2005;47:547-57
- Gurwitz JH, McLuaghlin TJ, Fish LS. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products. Health Serv Res 1995;30:672-85
- Lee LJ, DiBonaventura M, Kudel I, et al. The incremental effect of over-the-counter medications on work productivity and healthcare resource utilization among adults with pain in the United States. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 21st Annual International Meeting; May 21–25, 2016, Washington, DC
- Temin P. Realized benefits from switching drugs. J Law Econ 1992;35:351-69